Account
Articles
23.08.2021
Indirect treatment comparisons guide

ITC can provide an estimate of the relative treatment effect of two products that have not been comp...

Read more
Articles
14.07.2021
Market Access News Summary

We’ve prepared a summary of our key market access blogs and news articles from the second quarter ...

Read more
Articles
12.04.2021
Benefits of early dialogue with HTA

Remap Consulting has significant expertise in guiding companies through both EUnetHTA / EMA Parallel...

Read more
Articles
25.03.2021
Subscription style payment model

To tackle antibiotic resistance, novel antibiotics are being reserved as later-line therapy for more...

Read more
Articles
15.07.2020
What are payer archetypes

Payers are responsible for making choices on which products or services to fund from limited healthc...

Read more
Articles
19.03.2020
What is a Payer

"Payer" generally refers to people or bodies other than the patient that finance or refund the cost ...

Read more
Articles
29.05.2019
What are precision medicines

What is the future of precision medicine in the EU? The field of precision medicine is a complex are...

Read more
Case Study
21.02.2019
Payer insights for clinical trials

Understanding payer value and evidence requirements to secure pricing and reimbursement for an oncol...

Read more
Case Study
21.02.2019
Maximising product value through PSA

Supporting in identifying and obtaining payer scientific advice to inform a Phase III trial design.

Read more
Publications
17.01.2019
Early payer scientific advice procedures

The objective of this research was to understand the processes and outputs from different European p...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.